Petr Urbanek
Urbánek, Petr, 1969-
VIAF ID: 84058804 (Personal)
Permalink: http://viaf.org/viaf/84058804
Preferred Forms
-
100 0 _
‡a
Petr Urbanek
-
100 1 _ ‡a Urbánek, Petr, ‡d 1969-
4xx's: Alternate Name Forms (3)
Works
| Title | Sources |
|---|---|
| 559 CNS impairment in the children from patients with Wilson disease |
|
| Abnormální jaterní testy - suplementum 2023 |
|
| Chelating polymeric beads as potential therapeutics for Wilson's disease. |
|
| Chronická hepatitida na konci 20. století |
|
| Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms |
|
| Doporučené diagnostické a terapeutické postupy pro všeobecné praktické lékaře : supplementum |
|
| Effect of carvedilol on portal hypertension depends on the degree of endothelial activation and inflammatory changes |
|
| Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial. |
|
| Efficacy and safety of peginterferon α-2a (40 KD) plus ribavirin in treatment-naive chronic hepatitis C patients in Central and Eastern Europe |
|
| Epidemiology of HCV infection in the Central European region |
|
| Expression of Biliverdin Reductase A in peripheral blood leukocytes is associated with treatment response in HCV-infected patients |
|
| Functional variants of eNOS and iNOS genes have no relationship to the portal hypertension in patients with liver cirrhosis |
|
| Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitor |
|
| Hepatologie |
|
| Historical epidemiology of hepatitis C virus (HCV) in selected countries. |
|
| Immunological predictors of different responses to combination therapy with interferon alpha and ribavirin in patients with chronic hepatitis C. |
|
| Long-term follow-up of Wilson Disease: natural history, treatment, mutations analysis and phenotypic correlation |
|
| New therapeutic options for HCV in Central Europe |
|
| Obyčejné nemoci trávicího traktu |
|
| Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis. |
|
| Predictive role BLVRA mRNA expression in hepatocellular cancer |
|
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm |
|
| Propofol-induced acute pancreatitis. |
|
| Strategies to manage hepatitis C virus |
|
| Sustained virological response with telaprevir in 1,078 patients with advanced hepatitis C: the international telaprevir access program. |
|
| T helper, cytotoxic T lymphocyte, NK cell and NK-T cell subpopulations in patients with chronic hepatitis C |
|
| Toxic Epidermal Necrolysis After Exposure to Dithiocarbamate Fungicide Mancozeb. |
|
| Viral hepatitis infections in chronic kidney disease patients and renal transplant recipients |
|
| Virová hepatitida C |
|
| Zácpa |
|
